Author： Olivier Jr. Kenneth J. Price Karen D. Hutto David L. Lerche Nicholas W. Mansfield Keith G. Simmons Joe H. Taylor Katrina Myers L. Peyton Ouyang Yanli Evans Ellen W.
Publisher： Informa Healthcare
ISSN： 1547-691X
Source： Journal of Immunotoxicology, Vol.7, Iss.2, 2010-06, pp. : 138-146
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Non-human primates (NHP) are used to best understand and address pharmacology and toxicology obligations for human patients with highest and/or unmet need. In order to ensure the most appropriate care and use of NHP, it is important to understand the normal micro flora and fauna of NHP and ensure their utmost health to generate the most valuable and applicable data. There are many infections, including viral, bacterial, parasitic, and fungal that may perturb physiologic endpoints relevant to human health, and are essential to monitor and/or eradicate for NHP health. This publication captures a discussion involving the experience, knowledge and opinion from academic, industry and government experts regarding emerging and normal infections in NHP as they relate to immunotoxicity, and treatment and consequences of known infections.
Related content
Access to resources
Recommend
By Kamperschroer Cris Kaur Amitinder Lebrec Hervé
Journal of Immunotoxicology, Vol. 9, Iss. 1, 2012-03 ,pp. :
By Kawabata Thomas Weaver James Thomas Dolca Rowe Martin Wang Fred Kamperschroer Cris Haggerty Helen
Journal of Immunotoxicology, Vol. 9, Iss. 1, 2012-03 ,pp. :